NYSE: SGFYSignify Health Inc Stock
$30.47+1.66 (+5.76%)
Updated Mar 27, 2023
SGFY Price
$30.47
Fair Value Price
N/A
Market Cap
$7.21B
52 Week Low
$10.70
52 Week High
$30.48
P/E
-55.4x
P/B
11.49x
P/S
6.27x
PEG
N/A
Dividend Yield
N/A
Revenue
$805.50M
Earnings
-$576.80M
Gross Margin
45.3%
Operating Margin
-69.82%
Profit Margin
-71.6%
Debt to Equity
1.47
Operating Cash Flow
$32M
Beta
0.98
Next Earnings
May 2, 2023
Ex-Dividend
N/A
Next Dividend
N/A
SGFY Overview
Signify Health, Inc. operates a healthcare platform that utilizes analytics, technology, and healthcare provider networks in the United States. The company operates in two segments, Home & Community Services and Episodes of Care Services. The Home & Community Services segment offers health evaluations performed within the patient's home or at a healthcare provider facility primarily to Medicare Advantage health plans; diagnostic screening and other ancillary services; and services to address healthcare concerns related to social determinants of health. The Episodes of Care Services segment provides services to enhance the healthcare delivery through developing and managing episodic payment programs in partnership with healthcare providers primarily under the Medicare Bundled Payment for Care Improvement Advanced program with Centers for Medicare and Medicaid Services; and care management services. Its customers include health plans, governments, employers, health systems, and physician groups. The company was founded in 2017 and is headquartered in Dallas, Texas.
Zen Score
–
Industry Average (23)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how SGFY scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
SGFY is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
SGFY is poor value based on its book value relative to its share price (11.49x), compared to the US Health Information Services industry average (3.52x)
P/B vs Industry Valuation
SGFY is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 30 more SGFY due diligence checks available for Premium users.
Be the first to know about important SGFY news, forecast changes, insider trades & much more!
SGFY News
Valuation
SGFY price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-55.4x
Industry
3.27x
Market
21.44x
SGFY price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
11.49x
Industry
3.52x
SGFY is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation
SGFY's financial health
Profit margin
Revenue
$203.0M
Net Income
-$36.4M
Profit Margin
-17.9%
SGFY's Earnings (EBIT) of -$562.40M... subscribe to Premium to read more.
Interest Coverage Financials
SGFY's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$1.7B
Liabilities
$923.5M
Debt to equity
1.47
SGFY's short-term assets ($796.50M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
SGFY's short-term assets ($796.50M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
SGFY's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$8.6M
Investing
-$5.8M
Financing
$1.4M
SGFY's operating cash flow ($31.90M)... subscribe to Premium to read more.
Debt Coverage Financials
SGFY vs Health Information Service Stocks
Signify Health Stock FAQ
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.